O14965 (AURKA_HUMAN) Homo sapiens (Human)

Aurora kinase A UniProtKBInterProSTRINGInteractive Modelling

403 aa; Sequence (Fasta)

Available Structures

186 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structure of Aurora Kinase A in complex with activator peptide Heteromer
Q8TEP8;
123-390
100.0ADP;
Aurora-A kinase domain in complex with vNAR-D01 (crystal form 2) Heteromer
Q8JJ25;
126-392
99.62ADP;SO4; 10×EDO;
Aurora-A in complex with TACC3 Heteromer
Q9Y6A5;
126-392
99.22ADP;GOL;SO4;
Crystal structure of Aurora-A bound to a hydrocarbon-stapled proteomimetic of TPX2 Heteromer
Q9ULW0;
126-392
99.62ADP;PG4;SO4;PEG;MES;P4G;CL;MG;
Aurora-A kinase domain in complex with vNAR-D01 S93R Heteromer
Q8JJ25;
126-391
100.0ADP;EDO;PEG;
Structure of Aurora-A 122-403, phosphorylated on Thr287, Thr288 and bound to TPX2 1-43 Heteromer
Q9ULW0;
123-388
100ADP;MG;SO4;
Structure of dephosphorylated Aurora A (122-403) bound to TPX2 and AMPPCP Heteromer
Q9ULW0;
125-390
100ACP;SO4;
Aurora-A in complex with CEP192 and an inhibitory monobody Heteromer
Q8TEP8;
124-389
97.63ADP;GOL;MG;
Structure Aurora A (122-403) bound to activating monobody Mb1 and AMPPCP Heteromer
126-390
100ACP;MG;SO4;
Crystal structure of Aurora A in complex with VX-680 and TPX2 Heteromer
Q9ULW0;
125-389
100VX6;SO4;
Aurora-A kinase domain in complex with vNAR-D01 (crystal form 1) Heteromer
Q8JJ25;
126-389
99.62ADP;SO4;EDO;
Crystal structure of Aurora-A kinase in complex with N-Myc Heteromer
P04198;
126-389
99.62ADP;MG;
Crystal structure of a covalently linked Aurora-A N-Myc complex Heteromer
P04198;
126-389
99.24ADP;MG;GOL;BCN;NA;JWG;
Crystal structure of aurora A in complex with TPX2 and compound 10 Heteromer
Q9ULW0;
125-388
1002JZ;
AurA bound to danusertib and activating monobody Mb1 Heteromer
126-389
100EDO;SO4;MES;PO4;PDO;627;
AurA bound to danusertib and inhibiting monobody Mb2 Heteromer
127-389
100.0EDO;ACT;627;
Structure of Aurora A (122-403) bound to inhibitory Monobody Mb2 and AMPPCP Heteromer
127-389
100.0ACP;
Structure of dephosphorylated Aurora A (122-403) in complex with inhibiting monobody and AT9283 in … Heteromer
127-388
100.035R;
Aurora A Kinase Apohomo-4-mer125-390
99.62
TPX2 residues 7-20 fused to Aurora A residues 116-389 with C290 disulfide bonded to compound 8-34, …homo-2-mer104-389
100MG;AMP;R74;MLA;
TPX2 residues 7-20 fused to Aurora A residues 116-389 with C290 disulfide bonded to compound 7-80, …homo-2-mer104-389
100MG;ANP;MLA;R7D;GOL;
TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + D256N + C319V triple mutant disulfide…homo-2-mer104-389
100ANP;MG;MLA;
TPX2 residues 7-20 fused to Aurora A residues 116-389 modified with cacodylate and in complex with …homo-2-mer104-389
100CL;DTD;ANP;GOL;
TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated,…homo-2-mer117-389
99.24GLC;ANP;
Crystal structure of Aurora A 122-403 C290A, N332A, Q335A, C393A bound to ADPhomo-2-mer126-390
98.87ADP;EPE;GOL;MPO;NO3;MG;
Aurora A in complex with a bisanilinopyrimidinehomo-2-mer126-388
100.048B;SO4;
Aurora A ligand complexhomo-2-mer128-389
100.0SO4;EG7;
Aurora A ligand complexhomo-2-mer128-388
100.0EGJ;DMS;SO4;
AURORA KINASE A IN COMPLEX WITH THE AUR-A/PDK1 INHIBITOR VI8monomer117-390
100.0V0K;
TPX2 residues 7-20 fused to Aurora A residues 116-389 in complex with AMP-PNPmonomer117-389
100.0ANP;GOL;CL;MG;
Aurora A in complex with ADPmonomer124-394
99.63MG;ADP;
Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and sp…monomer126-394
100.0MMH;
Identification, SAR Studies and X-ray Cocrystal Analysis of a Novel Furano-pyrimidine Aurora Kinase…monomer126-394
100.0PFQ;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer125-392
99.63ADP;MG;A8K;CL;
SAR156497 an exquisitely selective inhibitor of Aurora kinasesmonomer125-392
100.0JVE;
Aurora A inhibitor complexmonomer124-391
98.8897B;
Aurora-2 T287D T288D complexed with PHA-680632monomer127-394
100.0MPY;
Crystal structure of Aurora A in complex with 7-(2-Anilinopyrimidin-4-yl)-1-benzazepin-2-one deriva…monomer125-392
100.0S9K;
SAR156497 an exquisitely selective inhibitor of Aurora kinasesmonomer125-391
100.0Y3M;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer125-391
99.62ADP;MG;A9B;CL;
Crystal Structure of Aurora2 kinase in complex with a GSK3beta inhibitormonomer125-391
100.0OFI;
Crystal structure of Aurora-A L210C catalytic domain in complex with ASDO6 ligandmonomer127-393
99.22G7T;CL;ACT;PGF;
Crystal structures of human kinase Aurora Amonomer125-391
99.61ADN;
Aurora A in complex with YL1-038-31monomer124-390
99.620BX;
Aurora A in complex with CD532monomer125-390
99.62CJ5;MG;PO4;DMS;EDO;
Crystal structure of Aurora A (STK6) in complex with macrocycle ODS2003208monomer124-389
100.0CIT;EDO;Q7Q;
Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetocho…monomer126-391
100.0VX6;
Aurora A in complex with RPM1686monomer124-389
99.620C8;EDO;
Aurora A in complex with YL1-038-18monomer124-389
99.62EDO;NHI;
Aurora A in complex with RPM1680monomer124-389
99.620C0;EDO;
Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetocho…monomer126-391
99.62WPH;
Complex of Aurora-A bound to an Imidazopyridine-based inhibitormonomer126-391
100.0VEK;SO4;
Crystal structures of human kinase Aurora Amonomer126-391
100.0ADN;
Aurora A in complex with RPM1693monomer124-389
99.620C3;EDO;PEG;
Crystal structures of human kinase Aurora Amonomer126-391
99.61ADN;
Crystal Structure of Aurora A Kinase complexed with inhibitormonomer126-391
100.0AKI;
Crystal structure of Aurora A in complex with 7-(2-Anilinopyrimidin-4-yl)-1-benzazepin-2-one deriva…monomer125-390
100.0S9H;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;CL;A4W;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A6Z;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A7N;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;CL;A65;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A8H;SO4;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A6H;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A9E;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A98;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;CL;A7H;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;CL;A6W;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A7K;
Aurora-A in complex with shape-diverse fragment 55monomer127-391
99.62ADP;GOL;MG;CL;JRT;
Aurora A Kinase in complex with ATP in space group P41212monomer126-390
100MG;SO4;ATP;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A5W;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;CL;AY4;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A6E;
Aurora-A in complex with shape-diverse fragment 58monomer127-391
99.62ADP;MG;CL;JRW;
Aurora-A in complex with shape-diverse fragment 57monomer127-391
99.62ADP;MG;CL;JRQ;
Aurora A in complex with ATP and AA35.monomer125-389
100MG;5DN;SO4;ATP;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A5Q;CL;
Crystal structure of Aurora A 122-403 C290A, C393A bound to ADPmonomer127-391
99.62ADP;GOL;MG;CL;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A5H;
Aurora-A in complex with shape-diverse fragment 56monomer127-391
99.62ADP;MG;CL;JSN;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A5K;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A5E;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;A7Q;
Aurora A kinase activated mutant (T287D) in complex with ADPNPmonomer126-390
100.0GOL;PO4;ANP;
Aurora-A in complex with shape-diverse fragment 39monomer127-391
100.0ADP;MG;JSB;
Structure of dephosphorylated Aurora A (122-403) bound to AMPPCP in an active conformationmonomer128-392
100.0ACP;MG;
Reversible lysine-targeted probes reveal residence time-based kinase selectivity in vivomonomer127-391
99.615YZ;CL;
Aurora-A Inhibitor Structuremonomer125-389
98.87ZZL;EDO;ACT;DMS;
Crystal Structure of Aurora-A L210C catalytic domain in complex with ASDO2monomer127-391
99.22G7W;SO4;CL;
Novel Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetocho…monomer126-390
100.0YPH;
Aurora-A kinase domain in complex with Coenzyme Amonomer127-391
100COA;MG;PEG;
Crystal structure of Aurora-A kinase in complex with an allosterically binding fragmentmonomer127-391
99.62ADP;MG;CL;A5Z;
Crystal structure of Aurora-A in complex with FMF-03-145-1 (compound 2)monomer127-391
100.09YQ;
Aurora A kinase in complex with 2-(3-chloro-5-fluorophenyl)quinoline-4-carboxylic acid and JNJ-7706…monomer126-390
100.09QT;SKE;MG;
Crystal Structure of Aurora Kinase A in complex with BENZO[C][1,8]NAPHTHYRIDIN-6(5H)-ONEmonomer125-389
100XU1;
Aurora A in complex with YL5-81-1monomer125-389
99.620C6;
Aurora A in complex with YL1-038-21monomer124-388
99.62NHU;EDO;
Crystal Structure of Aurora Kinase A in complex with N-{4-[(6-oxo-5,6-dihydrobenzo[c][1,8]naphthyri…monomer126-390
100.0XU2;
Aurora A kinase in complex with TPX2-inhibitor 9monomer126-389
100MG;SO4;CL;DMS;ACT;ADP;T5L;GOL;T0L;
Structure of Aurora-2 in complex with PHA-680626monomer126-389
100626;ARS;
Aurora A Kinase in Complex with ATP in Space Group P6122monomer127-390
100.0MG;ATP;
Aurora A Kinase in Complex with JNJ-7706621 in Space Group P6122monomer127-390
100.0SKE;
Crystal Structure of Aurora A Kinase Domain Bound to MK-5108monomer127-390
100.05VC;
Aurora A Kinase in Complex with ATP in Space Group P6122monomer127-390
100MG;SO4;ATP;
Aurora A Kinase in Complex with AA29 and JNJ-7706621 in Space Group P6122monomer127-390
100.0SKE;5E2;
Aurora-A kinase complexed with AMPPNPmonomer126-389
100.0SO4;ANP;
Aurora A Kinase in Complex with AA30 and JNJ-7706621 in Space Group P6122monomer127-390
100.05E1;SKE;
Human AURKA bound to BRD-7880monomer126-389
100.0F8Z;
Structure of Aurora-A bound to a selective imidazopyrazine inhibitormonomer127-390
100.0A0H;
Structure of Human Aurora-A 122-403 phosphorylated on Thr287, Thr288monomer127-390
100ADP;MG;
Aurora A kinase domain with compound 2 (N-[1-(3-cyanobenzyl)-1H-pyrazol-4-yl]-6-(1H-pyrazol-4-yl)-1…monomer125-388
98.412VU;
Aurora A in complex with RPM1722monomer126-389
99.620C4;EDO;
Aurora A in complex with YL5-083monomer126-389
99.620BY;EDO;
Aurora A Kinase in Complex with AA35 and ATP in Space Group P6122monomer127-390
100.0MG;5DN;ATP;
AURORA-A T288E COMPLEXED WITH PHA-828300monomer126-389
100.0400;
Design, synthesis, and biological evaluation of pyrazolopyridine-sulfonamides as potent multiple-mi…monomer126-389
100.0D37;
Aurora A kinase in complex with 2-(3-fluorophenyl)quinoline-4-carboxylic acid and ATPmonomer127-390
100.0MG;SO4;ATP;9QK;
Aurora A Kinase in Complex with AA35 and ATP in Space Group P6122monomer127-390
100.0MG;5DN;ATP;
Aurora A in complex with RK2-17-01monomer125-388
99.62NHJ;EDO;
Aurora A in complex with YL1-038-09monomer124-387
99.620C9;
Crystal Structure of Aurora-A Protein Kinasemonomer126-388
100.0MG;PO4;ADP;
Aurora A kinase in complex with TPX2-inhibitor 6monomer126-388
100.0ADP;MG;GOL;T5L;SO4;DMS;T2O;
Crystal structure of benzamide 9 bound to AuroraAmonomer126-388
100.0LJE;
Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitormonomer127-389
100.0HPM;
Aurora A Kinase in Complex with AA35 and JNJ-7706621 in Space Group P6122monomer127-389
100.05DN;SKE;
Structure of AuroraA with pyridyl-pyrimidine urea inhibitormonomer126-388
100.0AK8;SO4;
Aurora A in complex with SO2-162monomer127-389
99.620C7;EDO;
Aurora A Kinase complexed with SCH 1473759monomer126-388
100.0PG4;EML;
Aurora A kinase in complex with TPX2-inhibitor 3monomer126-388
100.0ADP;MG;T4C;T5L;SO4;DMS;ACT;
Structure of apo, dephosphorylated Aurora A (122-403) in an active conformationmonomer127-389
100.0P4G;
Aurora A Kinase in Complex with AA30 and ATP in Space Group P6122monomer128-390
99.625E1;MG;ATP;
Crystal structure of V174M mutant of Aurora-A kinasemonomer126-388
99.62ADP;CA;
Structure of Aurora kinase A complexed to benzoimidazole-indazole inhibitor XIIImonomer126-388
100.0N13;
Aurora A kinase bound to a highly selective imidazopyridine inhibitormonomer126-388
100.0FH3;
Aurora kinase A complexed to pyrazole aminoquinoline Imonomer126-388
99.24RO9;
Structure determination of Aurora Kinase in complex with inhibitormonomer127-389
100.0L0G;
Aurora A kinase bound to a highly selective imidazopyridine inhibitormonomer126-388
100.0FH5;
Aurora A kinase bound to an imidazopyridine inhibitor (14a)monomer126-388
100.0NL4;
Aurora-A bound to an inhibitormonomer126-388
100.0SO4;X6D;
Aurora A in Complex with RPM1679monomer127-389
99.620BZ;EDO;
Structure of Aurora kinase A complexed to pyrazole-aminoquinoline inhibitor IIImonomer126-388
100.0P9J;
Aurora A kinase domain with phthalazinone pyrazole inhibitormonomer126-388
100.0P9J;
Aurora A kinase in complex with TPX2-inhibitor 10monomer126-388
100.0ADP;MG;T1L;T5L;SO4;DMS;ACT;
Aurora A kinase in complex with TPX2-inhibitor 2monomer127-389
100MG;T4X;ADP;
Structure determination of Aurora Kinase in complex with inhibitormonomer127-389
100.0L0F;
Crystal Structure of Aurora-A in complex with a new Quinazoline inhibitormonomer127-389
100.09A6;
The crystal structure of human AURKA kinase domain in complex with AURKA-compound 9monomer127-389
100.0C0N;
Design, synthesis, and biological evaluation of pyrazolopyridine-sulfonamides as potent multiple-mi…monomer127-389
100.0D36;MG;
The crystal structure of human aurka kinase domain in the complex with aurka-compound 25monomer127-389
100.0C74;
Aurora A in complex with RPM1715monomer127-389
99.620C5;
Structure determination of Aurora Kinase in complex with inhibitormonomer127-389
100.0L0E;
The crystal structure of human aurka kinase domain in complex with AURKA-A2monomer127-389
100.0E47;
Structure determination of Aurora Kinase in complex with inhibitormonomer127-389
100.0L0D;
Imidazo[1,2-a]pyrazine-based Aurora Kinase Inhibitorsmonomer126-388
99.24NRM;
Aurora A kinase bound to an imidazopyridine inhibitor (14d)monomer126-388
100.07HD;
Crystal structure of anthranilamide 10 bound to AuroraAmonomer126-388
100.0LJF;
Structure determination of Aurora Kinase in complex with inhibitormonomer127-389
100L0C;
Aurora-A bound to an inhibitormonomer126-388
100.0YM4;
Structure of Human Aurora A in Complex with a diaminopyrimidinemonomer126-388
99.6E9Z;
Aurora A kinase in complex with TPX2-inhibitor 7monomer127-388
100.0T3I;ADP;MG;GOL;T5L;SO4;DMS;ACT;
Aurora A kinase in complex with TPX2-inhibitor 9monomer127-388
100.0T2F;ADP;MG;T5L;SO4;DMS;ACT;
Aurora A kinase in complex with TPX2-inhibitor 8monomer127-388
100.0T3U;ADP;MG;T5L;SO4;DMS;ACT;CL;
Structural Basis for the Inhibition of Aurora A Kinase by a Novel Class of High Affinity Disubstitu…monomer127-388
100.0SO4;CC3;
Aurora A kinase in complex with TPX2-inhibitor CAM2602monomer127-388
99.62T4O;ADP;MG;T5L;SO4;DMS;ACT;
Structure of S155R Aurora-A somatic mutantmonomer127-388
99.58ADP;
TPX2 residues 7-20 fused to Aurora A residues 116-389 dephosphorylated, and CoAlated on C290monomer127-388
100.0COA;
Synthesis and SAR Studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off ta…monomer127-388
100.00FY;
Structure of dephosphorylated Aurora A (122-403) bound to AMPPCPmonomer127-388
100.0ACP;
Aurora A kinase in complex with TPX2-inhibitor 9monomer127-388
100T0X;MG;ATP;
Structure of Aurora A mutant bound to Biogenidec cpd 15monomer128-389
100.00K6;PO4;MG;
Structure of Aurora-A bound to an imidazopyrazine inhibitormonomer127-388
99.59ASH;
Human Aurora A catalytic domain bound to FK932monomer127-388
100.04RM;MPD;
Aurora A kinase bound to an imidazopyridine inhibitor (14b)monomer127-388
100.06F2;
Human Aurora A catalytic domain bound to FK1141monomer127-388
100.04RJ;
Human Aurora A catalytic domain bound to FK1142monomer127-388
100.04RK;MPD;
STRUCTURE OF AURORA A IN COMPLEX WITH MLN8054monomer127-388
100.0ZZL;
Human Aurora A catalytic domain bound to SB-6-OHmonomer127-388
100.04QV;
Structure of Aurora-2 in complex with PHA-739358monomer128-389
100.0627;SO4;
Aurora A kinase bound to an imidazopyridine inhibitor (7a)monomer127-388
100.05GX;SO4;
SAR156497 an exquisitely selective inhibitor of Aurora kinasesmonomer127-388
100.0QMN;
Aurora-A Inhibitor Structure (2nd crystal form)monomer128-389
98.83ZZL;
Structure of Aurora kinase A complexed to benzoimidazole-indazole inhibitor XVmonomer128-388
100.0N15;
Crystal structure of Aurora-A in complex with a pentacyclic inhibitormonomer128-388
98.3883H;
CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASEmonomer128-388
100.0ADN;
Aurora A in complex with a bisanilinopyrimidinemonomer128-388
100.045B;
Structure of unphosphorylated D274N mutant of Aurora-Amonomer128-388
99.59ATP;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2j4z.2.Amonomer0.82126-394
626;100.00